US Appeal Against 2021 Cabazitaxel Patent Falls Flat

 
• By Aidan Fry
  
Cabazitaxel
US market entry for generic cabazitaxel by several leading players looks set to be pushed back to September 2021 at the earliest • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin